Immunodominant domains present on the Bordetella pertussis vaccine component filamentous hemagglutinin.

PubWeight™: 0.99‹?› | Rank: Top 15%

🔗 View Article (PMID 9180182)

Published in J Infect Dis on June 01, 1997

Authors

E Leininger1, S Bowen, G Renauld-Mongénie, J H Rouse, F D Menozzi, C Locht, I Heron, M J Brennan

Author Affiliations

1: Division of Bacterial Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland, USA.

Articles citing this

Subtilisin-like autotransporter serves as maturation protease in a bacterial secretion pathway. EMBO J (2001) 1.48

Role of adhesin release for mucosal colonization by a bacterial pathogen. J Exp Med (2003) 1.26

Purification and immunogenicity of a recombinant Bordetella pertussis S1S3FHA fusion protein expressed by Streptococcus gordonii. Appl Environ Microbiol (2002) 0.95

Natural-host animal models indicate functional interchangeability between the filamentous haemagglutinins of Bordetella pertussis and Bordetella bronchiseptica and reveal a role for the mature C-terminal domain, but not the RGD motif, during infection. Mol Microbiol (2009) 0.94

Subcutaneous vaccination with attenuated Salmonella enterica serovar Choleraesuis C500 expressing recombinant filamentous hemagglutinin and pertactin antigens protects mice against fatal infections with both S. enterica serovar Choleraesuis and Bordetella bronchiseptica. Infect Immun (2008) 0.91

Eighty-kilodalton N-terminal moiety of Bordetella pertussis filamentous hemagglutinin: adherence, immunogenicity, and protective role. Infect Immun (2002) 0.91

Immunogenicity and protective efficacy of a recombinant filamentous haemagglutinin from Bordetella pertussis. Clin Exp Immunol (2006) 0.90

Antigenic analysis of Bordetella pertussis filamentous hemagglutinin with phage display libraries and rabbit anti-filamentous hemagglutinin polyclonal antibodies. Infect Immun (1998) 0.83

Expression, Purification and Characterization of Three Overlapping Immunodominant Recombinant Fragments from Bordetella pertussis Filamentous Hemagglutinin. Avicenna J Med Biotechnol (2013) 0.79

Construction and characterization of single-chain variable fragment antibodies directed against the Bordetella pertussis surface adhesins filamentous hemagglutinin and pertactin. Infect Immun (2007) 0.75

Comparative efficacy of intranasal and injectable vaccines in stimulating Bordetella bronchiseptica-reactive anamnestic antibody responses in household dogs. Can Vet J (2017) 0.75

Articles by these authors

Automated high-throughput genotyping for study of global epidemiology of Mycobacterium tuberculosis based on mycobacterial interspersed repetitive units. J Clin Microbiol (2001) 9.80

Variable human minisatellite-like regions in the Mycobacterium tuberculosis genome. Mol Microbiol (2000) 8.10

High-resolution minisatellite-based typing as a portable approach to global analysis of Mycobacterium tuberculosis molecular epidemiology. Proc Natl Acad Sci U S A (2001) 6.97

Pertussis toxin gene: nucleotide sequence and genetic organization. Science (1986) 6.02

Rapid assay for screening and characterizing microorganisms for the ability to degrade polychlorinated biphenyls. Appl Environ Microbiol (1986) 5.69

Identification of novel intergenic repetitive units in a mycobacterial two-component system operon. Mol Microbiol (1997) 3.99

Extensive degradation of Aroclors and environmentally transformed polychlorinated biphenyls by Alcaligenes eutrophus H850. Appl Environ Microbiol (1987) 3.82

Proteins released from Mycobacterium tuberculosis during growth. Infect Immun (1991) 3.69

Evidence for novel mechanisms of polychlorinated biphenyl metabolism in Alcaligenes eutrophus H850. Appl Environ Microbiol (1987) 3.68

Polychlorinated biphenyl dechlorination in aquatic sediments. Science (1987) 3.64

The heparin-binding haemagglutinin of M. tuberculosis is required for extrapulmonary dissemination. Nature (2001) 2.65

Two-partner secretion in Gram-negative bacteria: a thrifty, specific pathway for large virulence proteins. Mol Microbiol (2001) 2.58

A technique for accessory cervical heart transplantation in rabbits and rats. Acta Pathol Microbiol Scand A (1971) 2.55

Investigation of the organization of mammalian chromosomes at the DNA sequence level. Fed Proc (1976) 2.54

Pertactin, an Arg-Gly-Asp-containing Bordetella pertussis surface protein that promotes adherence of mammalian cells. Proc Natl Acad Sci U S A (1991) 2.49

Activation of the pro-drug ethionamide is regulated in mycobacteria. J Biol Chem (2000) 2.43

T-cell proliferative response to antigens secreted by Mycobacterium tuberculosis. Infect Immun (1991) 2.43

The filamentous haemagglutinin, a multifaceted adhesion produced by virulent Bordetella spp. Mol Microbiol (1993) 2.39

Specificity of a protective memory immune response against Mycobacterium tuberculosis. Infect Immun (1993) 2.27

Comparative immune response to PE and PE_PGRS antigens of Mycobacterium tuberculosis. Infect Immun (2001) 2.26

Identification of a heparin-binding hemagglutinin present in mycobacteria. J Exp Med (1996) 2.18

Immunity against tetanus and effect of revaccination 25-30 years after primary vaccination. Lancet (1984) 2.16

Isolation and molecular characterization of a novel broad-host-range plasmid from Bordetella bronchiseptica with sequence similarities to plasmids from gram-positive organisms. Mol Microbiol (1992) 2.16

Search for a human breast cancer virus. Nature (1971) 2.14

Heparin-inhibitable lectin activity of the filamentous hemagglutinin adhesin of Bordetella pertussis. Infect Immun (1994) 2.06

American Cancer Society Lymphedema Workshop. Workgroup III: Diagnosis and management of lymphedema. Cancer (1998) 2.06

Identification of immunodominant antigens during infection with Mycobacterium tuberculosis. Scand J Immunol (1992) 2.05

Enhanced expression of beta2-microglobulin and HLA antigens on human lymphoid cells by interferon. Proc Natl Acad Sci U S A (1978) 1.98

Green fluorescent protein as a new expression marker in mycobacteria. Mol Microbiol (1995) 1.97

Identification of a new DNA region specific for members of Mycobacterium tuberculosis complex. J Clin Microbiol (1998) 1.96

Allergenic and blastogenic reactivity of three antigens from Mycobacterium tuberculosis in sensitized guinea pigs. Infect Immun (1987) 1.96

Comparison of type 2 and type 6 fimbriae of Bordetella pertussis by using agglutinating monoclonal antibodies. Infect Immun (1988) 1.92

Molecular cloning and complete sequence of prion protein cDNA from mouse brain infected with the scrapie agent. Proc Natl Acad Sci U S A (1986) 1.92

Comparative roles of the Arg-Gly-Asp sequence present in the Bordetella pertussis adhesins pertactin and filamentous hemagglutinin. Infect Immun (1992) 1.85

Specific differentiation between Mycobacterium bovis BCG and virulent strains of the Mycobacterium tuberculosis complex. J Clin Microbiol (1998) 1.84

Roles of the disulfide bond and the carboxy-terminal region of the S1 subunit in the assembly and biosynthesis of pertussis toxin. Infect Immun (1990) 1.83

Interaction of the Bordetella pertussis filamentous hemagglutinin with heparin. FEMS Microbiol Lett (1991) 1.81

Molecular characterization of the mycobacterial heparin-binding hemagglutinin, a mycobacterial adhesin. Proc Natl Acad Sci U S A (1998) 1.76

Beta-helix model for the filamentous haemagglutinin adhesin of Bordetella pertussis and related bacterial secretory proteins. Mol Microbiol (2001) 1.76

Rapid mycobacterial plasmid analysis by electroduction between Mycobacterium spp. and Escherichia coli. Nucleic Acids Res (1992) 1.75

Clonal expansion of a globally disseminated lineage of Mycobacterium tuberculosis with low IS6110 copy numbers. J Clin Microbiol (2004) 1.73

Agglutinating monoclonal antibodies that specifically recognize lipooligosaccharide A of Bordetella pertussis. Infect Immun (1988) 1.71

Binding of pertussis toxin to eucaryotic cells and glycoproteins. Infect Immun (1989) 1.71

Antibody responses against Mycobacterium tuberculosis in 11 strains of inbred mice: novel monoclonal antibody specificities generated by fusions, using spleens from BALB.B10 and CBA/J mice. Infect Immun (1988) 1.70

Epidemiological considerations of cancer of the gallbladder, bile ducts and salivary glands in the rubber industry. J Occup Med (1970) 1.68

Identification and characterization of a protective immunodominant B cell epitope of pertactin (P.69) from Bordetella pertussis. Eur J Immunol (1991) 1.67

Characterization of the protective capacity and immunogenicity of the 69-kD outer membrane protein of Bordetella pertussis. J Exp Med (1990) 1.67

Cloning, partial sequence, expression, and antigenic analysis of the filamentous hemagglutinin gene of Bordetella pertussis. Infect Immun (1990) 1.66

Molecular cloning of pertussis toxin genes. Nucleic Acids Res (1986) 1.64

Regulatory effect of interferon on T cells in vitro. J Immunol (1976) 1.62

Lectin-dependent attachment of Actinomyces naeslundii to receptors on epithelial cells. Infect Immun (1984) 1.56

Immunity against diphtheria 25-30 years after primary vaccination in childhood. Lancet (1985) 1.54

Sulfated glycoconjugate receptors for the Bordetella pertussis adhesin filamentous hemagglutinin (FHA) and mapping of the heparin-binding domain on FHA. Infect Immun (1994) 1.54

The modular architecture of bacterial response regulators. Insights into the activation mechanism of the BvgA transactivator of Bordetella pertussis. J Mol Biol (1994) 1.50

Identification of Bordetella pertussis infection by shared-primer PCR. J Clin Microbiol (1994) 1.49

Analysis of the Mycobacterium tuberculosis 85A antigen promoter region. J Bacteriol (1995) 1.48

Autotransporter proteins, evolution and redefining protein secretion: response. Trends Microbiol (2000) 1.48

Subtilisin-like autotransporter serves as maturation protease in a bacterial secretion pathway. EMBO J (2001) 1.48

Surface-associated filamentous hemagglutinin induces autoagglutination of Bordetella pertussis. Infect Immun (1994) 1.46

In vitro stimulation of human lymphocytes by purified cytomegalovirus. Intervirology (1977) 1.45

Identification and purification of transferrin- and lactoferrin-binding proteins of Bordetella pertussis and Bordetella bronchiseptica. Infect Immun (1991) 1.44

Monoclonal antibodies produced in BALB.B10 mice define new antigenic determinants in culture filtrate preparations of Mycobacterium tuberculosis. J Clin Microbiol (1988) 1.44

Fulminating encephalopathy associated with Shigella flexneri infection. Arch Dis Child (1983) 1.43

Type 2 fimbrial lectin-mediated phagocytosis of oral Actinomyces spp. by polymorphonuclear leukocytes. Infect Immun (1986) 1.40

Efficient homologous recombination in fast-growing and slow-growing mycobacteria. J Bacteriol (1996) 1.39

Filamentous hemagglutinin of Bordetella pertussis. A bacterial adhesin formed as a 50-nm monomeric rigid rod based on a 19-residue repeat motif rich in beta strands and turns. J Mol Biol (1994) 1.38

Mutational analysis of the Bordetella pertussis fim/fha gene cluster: identification of a gene with sequence similarities to haemolysin accessory genes involved in export of FHA. Mol Microbiol (1994) 1.38

Chondroitin/dermatan sulfate proteoglycan in human fetal membranes. Demonstration of an antigenically similar proteoglycan in fibroblasts. J Biol Chem (1984) 1.38

Safety and immunogenicity of a new Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in healthy adults. Vaccine (1999) 1.33

Distinct roles of the N-terminal and C-terminal precursor domains in the biogenesis of the Bordetella pertussis filamentous hemagglutinin. J Bacteriol (1996) 1.32

Functional domains present in the mycobacterial hemagglutinin, HBHA. J Bacteriol (1999) 1.32

ELISA for the routine determination of antitoxic immunity to tetanus. J Biol Stand (1986) 1.32

Simultaneous electroelution of whole SDS-polyacrylamide gels for the direct cellular analysis of complex protein mixtures. J Immunol Methods (1993) 1.32

The variability of estrogen receptors in metastatic breast cancer. Am J Surg (1979) 1.32

Characterization of the heparin-binding site of the mycobacterial heparin-binding hemagglutinin adhesin. J Biol Chem (2000) 1.31

Channel formation by FhaC, the outer membrane protein involved in the secretion of the Bordetella pertussis filamentous hemagglutinin. J Biol Chem (1999) 1.31

Modulation of the infant immune responses by the first pertussis vaccine administrations. Vaccine (2006) 1.29

New virulence-activated and virulence-repressed genes identified by systematic gene inactivation and generation of transcriptional fusions in Bordetella pertussis. J Bacteriol (2000) 1.29

Biological approaches for polychlorinated biphenyl degradation. Basic Life Sci (1988) 1.29

Delta-aminolaevulinic acid is a potent agonist for GABA autoreceptors. Nature (1979) 1.28

Biochemical characterization of acyl carrier protein (AcpM) and malonyl-CoA:AcpM transacylase (mtFabD), two major components of Mycobacterium tuberculosis fatty acid synthase II. J Biol Chem (2001) 1.26

Nucleotide sequence homology to pertussis toxin gene in Bordetella bronchiseptica and Bordetella parapertussis. Infect Immun (1987) 1.26

Evaluation of vaccination requirements to secure continuous antitoxin immunity to tetanus. Vaccine (1987) 1.25

Identification of AlcR, an AraC-type regulator of alcaligin siderophore synthesis in Bordetella bronchiseptica and Bordetella pertussis. J Bacteriol (1998) 1.24

Modification of the ELISA for the estimation of tetanus antitoxin in human sera. J Biol Stand (1987) 1.23

Fastin situ determination of the biomass of anchorage-dependent cells. Cytotechnology (1995) 1.22

Lack of functional complementation between Bordetella pertussis filamentous hemagglutinin and Proteus mirabilis HpmA hemolysin secretion machineries. J Bacteriol (1997) 1.20

Novel topological features of FhaC, the outer membrane transporter involved in the secretion of the Bordetella pertussis filamentous hemagglutinin. J Biol Chem (2000) 1.20